Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Pastore

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Genetic Counseling|May 3, 2014
Attitudes towards potentially carrying the FMR1 premutation: before vs after testing of non-carrier females with diminished ovarian reserveLisa M Pastore, Maria Antero, Karen Ventura, et al.
Reproductive Biomedicine Online|February 4, 2019
Does theFMR1 gene affect IVF success?Lisa M Pastore, Mindy S Christianson, Bailey McGuinness, et al.
Fertility and Sterility|November 7, 2016
Distribution of the FMR1 gene in females by race/ethnicity: women with diminished ovarian reserve versus women with normal fertility (SWAN study)Lisa M Pastore, Steven L Young, Ani Manichaikul, et al.
American Journal of Obstetrics and Gynecology|March 9, 2006
Acceptance of fragile X premutation genetic screening in women with ovarian dysfunctionLisa M Pastore, Logan B Karns, JoAnn V Pinkerton, et al.
Fertility and Sterility|January 30, 2007
Effect of endometrioma cyst fluid exposure on peritoneal adhesion formation in a rabbit modelLaura Proud Smith, Christopher D Williams, Joseph O'Brien Doyle, et al.
The Journal of Sexual Medicine|January 28, 2009
Sexual functioning of Latino women seeking outpatient gynecologic careKathie L Hullfish, Lisa M Pastore, Allyson J A Mormon, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 15, 2012
Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserveLisa M Pastore, Steven L Young, Valerie L Baker, et al.
Journal of Assisted Reproduction and Genetics|March 27, 2020
Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysisChristina N Cordeiro Mitchell, Bailey McGuinness, Eliana Fine, et al.
American Journal of Obstetrics and Gynecology|August 16, 2005
Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancerElise N Everett, Cara C Heuser, Lisa M Pastore, et al.
American Journal of Obstetrics and Gynecology|August 8, 2006
Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancerElise N Everett, Amy E French, Rebecca L Stone, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Genetic Counseling|May 3, 2014
Attitudes towards potentially carrying the FMR1 premutation: before vs after testing of non-carrier females with diminished ovarian reserveLisa M Pastore, Maria Antero, Karen Ventura, et al.
Reproductive Biomedicine Online|February 4, 2019
Does theFMR1 gene affect IVF success?Lisa M Pastore, Mindy S Christianson, Bailey McGuinness, et al.
Fertility and Sterility|November 7, 2016
Distribution of the FMR1 gene in females by race/ethnicity: women with diminished ovarian reserve versus women with normal fertility (SWAN study)Lisa M Pastore, Steven L Young, Ani Manichaikul, et al.
American Journal of Obstetrics and Gynecology|March 9, 2006
Acceptance of fragile X premutation genetic screening in women with ovarian dysfunctionLisa M Pastore, Logan B Karns, JoAnn V Pinkerton, et al.
Fertility and Sterility|January 30, 2007
Effect of endometrioma cyst fluid exposure on peritoneal adhesion formation in a rabbit modelLaura Proud Smith, Christopher D Williams, Joseph O'Brien Doyle, et al.
The Journal of Sexual Medicine|January 28, 2009
Sexual functioning of Latino women seeking outpatient gynecologic careKathie L Hullfish, Lisa M Pastore, Allyson J A Mormon, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 15, 2012
Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserveLisa M Pastore, Steven L Young, Valerie L Baker, et al.
Journal of Assisted Reproduction and Genetics|March 27, 2020
Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysisChristina N Cordeiro Mitchell, Bailey McGuinness, Eliana Fine, et al.
American Journal of Obstetrics and Gynecology|August 16, 2005
Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancerElise N Everett, Cara C Heuser, Lisa M Pastore, et al.
American Journal of Obstetrics and Gynecology|August 8, 2006
Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancerElise N Everett, Amy E French, Rebecca L Stone, et al.
Pageof 5